Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹5.25Admitted-Finance | ₹5.25 | L1 | Admitted-Finance |
| 2 | L2₹90.83+₹85.58 (1630.1%)Admitted-Finance 208 PHASE 3 OKHLA INDUSTRIAL ESTATE NEW DELHI DELHI 110020 | SOUTH EAST DELHI | DELHI | 110020 | ₹90.83+₹85.58 (1630.1%) | L2 | Admitted-Finance |
| 3 | L3₹115.50+₹110.25 (2100.0%)Admitted-Finance | ₹115.50+₹110.25 (2100.0%) | L3 | Admitted-Finance |
| 4 | L4₹178.67+₹173.42 (3303.2%)Admitted-Finance MSN HOUSE PLOT NO C 24 INDUSTRIAL ESTATE SANATHNAGAR HYDERABAD TELANGANA INDIA 500018 | HYDERABAD | HYDERABAD | TELANGANA | 500018 | ₹178.67+₹173.42 (3303.2%) | L4 | Admitted-Finance |
| 5 | L5₹186.27+₹181.02 (3448.0%)Admitted-Finance | ₹186.27+₹181.02 (3448.0%) | L5 | Admitted-Finance |
| Sl No | Description | Qty | Unit | SAMARTH LIFE SCIENCES PRIVATE LIMITED L14 | Theon Pharmaceuticals Limited L12 | MSN LABORATORIES PRIVATE LIMITED L4 | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED L46 | Glenmark Pharmaceuticals Limited L1 | Mankind Pharma Ltd. L2 | Fresenius Kabi Oncology Ltd L25 | Gufic Biosciences Ltd. L24 | LUPIN LIMITED L29 | Fresenius Kabi India Pvt Ltd L21 | BHARAT SERUMS AND VACCINES LIMITED L33 | Dr Reddys Laboratories Ltd L26 | HUSSAIN BROTHERS L9 | Cadila Pharmaceuticals Limited L6 | Roche Diagnostics India Pvt. Ltd. L8 | Intas Pharmaceuticals limited L39 | AstraZeneca Pharma India Limited L51 | ABBOTT INDIA LIMITED L41 | ABBOTT HEALTHCARE PRIVATE LIMITED L20 | BIOLOGICAL E LTD L16 | Serum Institute of India Ltd L3 | Zuvius Lifesciences Pvt Ltd L10 | Pfizer Limited L31 | Bayer Pharmaceuticals Private Limited L34 | GENNOVA BIOPHARMACEUTICALS LIMITED L48 | JODAS EXPOIM PRIVATE LIMITED L32 | Lifecare Innovations Pvt. Ltd. L30 | Naprod Life Sciences Pvt Ltd L28 | Roche Products (India) Pvt. Ltd. L50 | M/s Beta Drugs Limited L38 | ZYDUS LIFESCIENCES LIMITED L36 | Indian Immunologicals Limited L18 | AbbVie Healthcare India Pvt Ltd L40 | Novartis Healthcare Private Limited L23 | BDR PHARMACEUTICALS INTERNATIONAL PVT LTD L22 | PHARMA POINT L11 | Eli Lilly and Company (India) Pvt. Ltd. L42 | M/s. Macleods Pharmaceuticals Limited L7 | PROTECH TELELINKS L17 | Pearl Trading Co L15 | M/S SUNDAS ENTERPRISES L19 | VENUS REMEDIES LIMITED L13 | NATCO PHARMA LIMITED L43 | M/s. Hetero Healthcare Limited L5 | Merck Specialities Private Limited L49 | Reliance Life Sciences Pvt. Ltd. L45 | Takeda Biopharmaceuticals India Private Limited L47 | Johnson & Johnson Private Limited L44 | Pfizer Products India Private Limited L35 | OTSUKA PHARMACEUTICAL INDIA PRIVATE LIMITED L27 | UNITED BIOTECH PVT LTD L37 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.00Antibiotics/Antifungal/Others. (Free Hospital Items) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2.00 | Inj. Ciprofloxacin. | 1 | 200 mg./100 ml. | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 3.00 | Inj. Metronidazole 100 ml. | 1 | 500 mg./100 ml. | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 11 ₹11.55 Lowest | - |
| 4.00 | Inj. Fluconazole. | 1 | 2 mg./ml. | - | - | - | - | - | - | - | - | - | 45 ₹47.25 Lowest | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 5.00 | Inj. Etomidate | 1 | 2mg/ml | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 140 ₹147 Lowest | - | - | - | - | - | - | - | - | - | - | - | - |
| 6.00 | Inj. Cefoperazone + Salbactum Sod. | 1 | 1.5 gm. | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 34.5 ₹36.23 | 25.5 ₹26.78 Lowest | - | - | 34.9 ₹36.65 | - | - | - | - | - | - | - | - | - |
| 7.00 | Cap. Amoxicillin. | 1 | 500 mg. | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.19 ₹3.35 Lowest | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 8.00 | Tab. Azithromycin. | 1 | 500 mg. | - | - | - | - | - | - | - | - | - | - | - | 12.94 ₹13.59 | - | 10.27 ₹10.78 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 10.8 ₹11.34 | - | - | - | - | - | 9.17 ₹9.63 Lowest | - | - | - | - | - | - | - |
| 9.00 | Tab. Cefixime. | 1 | 200 mg. | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.7 ₹3.89 Lowest | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 10.00 | Tab. Ofloxacin+Ornidazole (Ofloxacin). | 1 | 200+500 mg. | - | - | - | - | - | 2.89 ₹3.03 | - | - | - | - | - | - | - | 1.93 ₹2.03 Lowest | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.4 ₹3.57 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Tender Value
₹40 Cr
EMD Value
₹2 L
Closing Date
30 Mar 2026, 6:00 pmClosed
MMO OFFICE P(I)
MMO OFFICE P(I)
Purchase of Drugs Medicines on two year Rate Contract basis
2026_SKIMS_301482_1
SIMS 325 P 1 Drugs Tender 02OF 2026DATED 27/01/2026
Open Tender
Medicines
Item Wise
SKIMS SOURA SRINAGAR
Please refer Tender documents.
25 documents required · 25 mandatory
₹2,000
Yes
DIRECTOR FINANCE SKIMS SOURA
₹2 L
Yes
16 Sept 2026
28 Jan 2026
31 Mar 2026
28 Jan 2026
30 Mar 2026
21 Feb 2026
28 Jan 2026 - 7 Feb 2026
| Sl No | Description | Qty | Unit | Est. Rate | Est. Amount |
|---|---|---|---|---|---|
| 1 | Antibiotics/Antifungal/Others. (Free Hospital Items) | - | - | - | - |
| 2 | Inj. Ciprofloxacin. | 1 | 200 mg./100 ml. | - | - |
| 3 | Inj. Metronidazole 100 ml. | 1 | 500 mg./100 ml. | - | - |
| 4 | Inj. Fluconazole. | 1 | 2 mg./ml. | - | - |
| 5 | Inj. Etomidate | 1 | 2mg/ml | - | - |
| 6 | Inj. Cefoperazone + Salbactum Sod. | 1 | 1.5 gm. | - | - |
| 7 | Cap. Amoxicillin. | 1 | 500 mg. | - | - |
| 8 | Tab. Azithromycin. | 1 | 500 mg. | - | - |
| 9 | Tab. Cefixime. | 1 | 200 mg. | - | - |
| 10 | Tab. Ofloxacin+Ornidazole (Ofloxacin). | 1 | 200+500 mg. | - | - |
stage.html
html • 0.13 MB
tech_eval.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.04 MB
Tendernotice_1.pdf
PDF • 1.29 MB
BOQ_978332.xls
BOQ • 1.10 MB
errata.pdf
PDF • 0.28 MB
DRUGS1.pdf
PDF • 0.36 MB
drugs.pdf
PDF • 0.30 MB
CG2.pdf
PDF • 0.10 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .